427 related articles for article (PubMed ID: 33272713)
1. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
[TBL] [Abstract][Full Text] [Related]
2. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
[TBL] [Abstract][Full Text] [Related]
3. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
[TBL] [Abstract][Full Text] [Related]
6.
Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and molecular docking studies of imines as α-glucosidase and α-amylase inhibitors.
Aispuro-Pérez A; López-Ávalos J; García-Páez F; Montes-Avila J; Picos-Corrales LA; Ochoa-Terán A; Bastidas P; Montaño S; Calderón-Zamora L; Osuna-Martínez U; Sarmiento-Sánchez JI
Bioorg Chem; 2020 Jan; 94():103491. PubMed ID: 31818480
[TBL] [Abstract][Full Text] [Related]
8. 2-Aryl benzimidazoles: Synthesis, In vitro α-amylase inhibitory activity, and molecular docking study.
Adegboye AA; Khan KM; Salar U; Aboaba SA; Kanwal ; Chigurupati S; Fatima I; Taha M; Wadood A; Mohammad JI; Khan H; Perveen S
Eur J Med Chem; 2018 Apr; 150():248-260. PubMed ID: 29533872
[TBL] [Abstract][Full Text] [Related]
9. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
[TBL] [Abstract][Full Text] [Related]
11. Exploring efficacy of indole-based dual inhibitors for α-glucosidase and α-amylase enzymes: In silico, biochemical and kinetic studies.
Kawde AN; Taha M; Alansari RS; Almandil NB; Anouar EH; Uddin N; Rahim F; Chigurupati S; Nawaz M; Hayat S; Ibrahim M; Elakurthy PK; Vijayan V; Morsy M; Ibrahim H; Baig N; Khan KM
Int J Biol Macromol; 2020 Jul; 154():217-232. PubMed ID: 32173438
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of a Series of Oleanolic Acid Saponins as α-Glucosidase and α-Amylase Inhibitors.
Guo T; Wu S; Guo S; Bai L; Liu Q; Bai N
Arch Pharm (Weinheim); 2015 Sep; 348(9):615-28. PubMed ID: 26207761
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study.
Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM
Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives.
Nawaz M; Taha M; Qureshi F; Ullah N; Selvaraj M; Shahzad S; Chigurupati S; Abubshait SA; Ahmad T; Chinnam S; Hisaindee S
J Biomol Struct Dyn; 2022; 40(21):10730-10740. PubMed ID: 34463216
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional isoxazolidine derivatives as α-amylase and α-glucosidase inhibitors.
Ghabi A; Brahmi J; Alminderej F; Messaoudi S; Vidal S; Kadri A; Aouadi K
Bioorg Chem; 2020 May; 98():103713. PubMed ID: 32151966
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyridines as potential α-amylase and α-glucosidase inhibitors: Synthesis, in vitro and in silico studies.
Yousuf H; Shamim S; Khan KM; Chigurupati S; Kanwal ; Hameed S; Khan MN; Taha M; Arfeen M
Bioorg Chem; 2020 Mar; 96():103581. PubMed ID: 31978686
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
18. Tetra-aryl cyclobutane and stilbenes from the rhizomes of Rheum undulatum and their α-glucosidase inhibitory activity: Biological evaluation, kinetic analysis, and molecular docking simulation.
Ha MT; Kim M; Kim CS; Park SE; Kim JA; Woo MH; Choi JS; Min BS
Bioorg Med Chem Lett; 2020 Apr; 30(8):127049. PubMed ID: 32111435
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
[TBL] [Abstract][Full Text] [Related]
20. Isatin thiazoles as antidiabetic: Synthesis, in vitro enzyme inhibitory activities, kinetics, and in silico studies.
Solangi M; Kanwal ; Khan KM; Chigurupati S; Saleem F; Qureshi U; Ul-Haq Z; Jabeen A; Felemban SG; Zafar F; Perveen S; Taha M; Bhatia S
Arch Pharm (Weinheim); 2022 Jun; 355(6):e2100481. PubMed ID: 35355329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]